UK markets closed
  • FTSE 100

    +45.88 (+0.65%)
  • FTSE 250

    +125.37 (+0.55%)
  • AIM

    +3.03 (+0.24%)

    +0.0009 (+0.07%)

    -0.0060 (-0.42%)

    +306.02 (+1.21%)
  • CMC Crypto 200

    -17.62 (-1.87%)
  • S&P 500

    +8.26 (+0.19%)
  • DOW

    +13.36 (+0.04%)

    +0.49 (+0.70%)

    -16.90 (-0.89%)
  • NIKKEI 225

    -9.83 (-0.03%)

    +103.25 (+0.36%)
  • DAX

    +122.05 (+0.78%)
  • CAC 40

    +54.17 (+0.83%)

Viral Inactivation Market Research Report by Method, by Product, by Application, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

·5-min read

Viral Inactivation Market Research Report by Method (Pasteurization and Solvent Detergent Method), by Product (Kits & Reagents, Services, and Viral Inactivation Systems & Accessories), by Application, by End User, by Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2026 - Cumulative Impact of COVID-19

New York, June 10, 2021 (GLOBE NEWSWIRE) -- announces the release of the report "Viral Inactivation Market Research Report by Method, by Product, by Application, by End User, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19" -

The Global Viral Inactivation Market size was estimated at USD 654.45 Million in 2020 and expected to reach USD 746.71 Million in 2021, at a Compound Annual Growth Rate (CAGR) 14.43% from 2020 to 2026 to reach USD 1,469.76 Million by 2026.

Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Viral Inactivation to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Method, the Viral Inactivation Market was studied across Pasteurization and Solvent Detergent Method.

Based on Product, the Viral Inactivation Market was studied across Kits & Reagents, Services, and Viral Inactivation Systems & Accessories.

Based on Application, the Viral Inactivation Market was studied across Blood & Blood Product, Cellular & Gene Therapy Product, Stem Cell Product, Tissues & Tissue Product, and Vaccines & Therapeutic.

Based on End User, the Viral Inactivation Market was studied across Academic Research Institutes, Contract Research Organizations, and Pharmaceutical & Biotechnology Companies.

Based on Geography, the Viral Inactivation Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Viral Inactivation Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Viral Inactivation Market, including Agilent Technologies, Avance Biosciences, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biospherix, Ltd, Charles River Laboratories International, Inc., Clean Cells Inc., Danaher Corporation, Eppendorf AG, Eurofins Scientific, F. Hoffmann-La Roche Ltd, General Electric, HiMedia Laboratories, Hospitech, Lonza Group AG, Merck KGaA, Novogene Co., Ltd., Parker Hannifin Corporation, Pfizer Inc., PromoCell GmbH, Rad Source Technologies, Inc., Sartorius AG, SGS SA, Texcell, Inc., Thermo Fisher Scientific Inc, Viral Inactivated Plasma Systems SA, Vironova AB, and Wuxi Pharmatech Inc..

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Viral Inactivation Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Viral Inactivation Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Viral Inactivation Market?
4. What is the competitive strategic window for opportunities in the Global Viral Inactivation Market?
5. What are the technology trends and regulatory frameworks in the Global Viral Inactivation Market?
6. What is the market share of the leading vendors in the Global Viral Inactivation Market?
7. What modes and strategic moves are considered suitable for entering the Global Viral Inactivation Market?
Read the full report:

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.


CONTACT: Clare: US: (339)-368-6001 Intl: +1 339-368-6001